ARDT · Ardent Health, Inc.
$10.61
+0.19 (+1.82%)
At close · Jul 24
Market Cap
$1.49B
Shares
143.35M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.42
Open$10.17
Day$10.03–10.42
52W$7.71–15.48
Avg vol 30d551K
Short int4.6M · 3.2% float · 8.4d
Short vol34%
Last earningsAug 5, 2026
DataJul 2024–Jul 2026
Filing10-Q · May 6
Up next
Next earnings call
Aug 5, 2026
Scheduled
· in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 6, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+4%
above
Price vs 50-day avg
+8%
above
RSI (14)
59
neutral
MACD trend
Positive
52-week position
35%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+11%
trailing
6-month return
+26%
trailing
YTD return
+18%
this year
Relative strength
+20%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $10 › 200d $10 — 200d above 50d
Institutional flow
Accumulating
14 of 135 funds reported for Jun 30 · net +202.0K sh shares · +2 new
Insider flow
Accumulating
Net +$186.4K over 90 days · 0% sells
Short interest
Rising
3.22% of float · ▲ +2.6% MoM · 8.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
135 holders — near 1-yr high, broad support
Squeeze score
65
elevated · 0–100
Fundamentals
Revenue growth
+6%
Y/Y
EPS growth
−39%
Y/Y
Valuation
P/E 11
below peers
Balance sheet
$389.6M
net debt
Quant / Vol
risk profile
Volatility
54%
annualized · 1-yr
Max drawdown
−49%
past year
ATR
4.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 5, 2026
Total revenue
· Full Year 2026
Initiated
$6.4B – $6.7B
prior FY $6.32B
midpoint +3.6% Y/Y
Net income attributable to Ardent Health, Inc.
· Full Year 2026
Initiated
$129M – $183M
Adjusted EBITDA
· Full Year 2026
Non-GAAP
Maintained
$485M – $535M
Rent expense payable to REITs
· Full Year 2026
Initiated
$168M
Diluted earnings per share
· Full Year 2026
Initiated
$0.90 – $1.27
prior FY $0.96
midpoint +13.0% Y/Y
Adjusted admissions growth
· Full Year 2026
Initiated
1.5% – 2.5%
Capital expenditures
· Full Year 2026
Initiated
$225M – $265M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+4%
Bullish
Price vs 50-day avg
+8%
Bullish
RSI (14)
59
Neutral
MACD trend
Positive
Bullish
52-week position
35%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $10 › 200d $10 — 200d above 50d
Institutional flow
Accumulating
14 of 135 funds reported for Jun 30 · net +202.0K sh shares · +2 new
Insider flow
Accumulating
Net +$186.4K over 90 days · 0% sells
Short interest
Rising
3.22% of float · ▲ +2.6% MoM · 8.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
135 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $8
Now $10 · 35%
52-wk high $15
vs 200-day avg +4%
vs 50-day avg +8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted admissions | 86,244 | three months ended March 31, 2026 | — |
|
|
|||
| Adjusted EBITDA non-GAAP | $124M | first quarter 2026 | — |
|
|
|||
| Admissions | 40,932 | three months ended March 31, 2026 | — |
|
|
|||
| Inpatient surgeries | 9,256 | three months ended March 31, 2026 | — |
|
|
|||
| Lease-adjusted net leverage ratio | 2.6 | as of March 31, 2026 | — |
|
|
|||
| Net patient service revenue per adjusted admission | $18,367 | three months ended March 31, 2026 | — |
| Outpatient surgeries | 22,086 | three months ended March 31, 2026 | — |
| Total surgeries | 31,342 | three months ended March 31, 2026 | — |
|
|
|||
| Adjusted EBITDA margin non-GAAP | 8.6% | full-year 2025 | — |
| Share repurchases | 0.35M | Q4 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ARDT
this stock
Ardent Health, Inc.
|
$1.49B | +18.0% | +6.0% | 11.0 | 3.2% |
|
HCA
HCA Healthcare, Inc.
|
$83.52B | -19.2% | +7.1% | 13.0 | 2.6% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$27.71B | -14.2% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$19.99B | +0.2% | -2.3% | 12.1 | 3.5% |
|
DVA
Davita Inc.
|
$15.04B | +106.2% | +6.5% | 21.9 | 7.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ARDT | +2.2% | +10.9% | +26.5% | +5.9% | +18.0% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | +3.8% | +10.2% | +20.1% | +7.0% | +9.8% |
Key facts
CIK
1756655
CUSIP
03980N107
13F (30d)
15 filings
15 filers
Visit website
Investor relations